Examinando por Autor "Aguilar Güimac, Eduar Glicerio"

Seleccione resultados tecleando las primeras letras
Mostrando 1 - 1 de 1
  • Miniatura
    PublicaciónAcceso abierto
    Estudio etnofarmacológico de las plantas medicinales con mayor uso significativo en la comunidad del centro poblado Tambolic, distrito de Jamalca, Utcubamba – Amazonas. Mayo–junio de 2018
    (Universidad Privada Norbert Wiener, 2019-09-06) Aguilar Güimac, Eduar Glicerio; Montalvo Rodriguez, Gina Pilar; Félix Véliz, Luis Miguel Visitación
    The objective of this research was to identify, through an ethnopharmacological study, the medicinal plants with the greatest significant use in the community of the Tambolic populated center, Jamalca district, Utcubamba – Amazonas, during May-June 2018. Method: The recommendations established by the Traditional Medicine of the Islands (TRAMIL) were followed, considering two working stages: field and post-field. The field stage involved semi-structured interviews with 54 people (men and women of older age in the family group). The post-field stage involved the analysis of the TRAMIL significant use level index and phytochemical analysis. Results: 31 plants with medicinal uses were reported, distributed across 23 families, with the Lamiaceae family being the most representative, with three species: Rosmarinus officinalis L. (Rosemary), Mentha pulegium L. (Pennyroyal), and Ocimum basilicum L. (Basil). The gastrointestinal category was the most frequent ailment. It was also determined that the leaves are the most utilized parts of the plants (56.76%). The most habitual mode of preparation is infusion (26.47%). The primary route of administration is oral (62.86%), followed by the topical route (25.17%). Conclusion: The ethnopharmacological study identified that the medicinal species with the greatest significant use in the Tambolic populated center community are: Mentha pulegium L. (Pennyroyal), Plantago major L. (Plantain), and Verbena officinalis L. (Vervain). All of them were cited with a frequency greater than 20% for a specific health problem.